UBS Maintains a 'Buy' on C.H. Robinson (CHRW); Raises PT & Estimates After Q2 Results
Tweet Send to a Friend
UBS maintains a 'Buy' on C.H. Robinson (Nasdaq: CHRW), raises PT from $71 to $75.
UBS analyst says, "While H2/10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst says, "While H2/10 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
